Stocktoria
ADIAL PHARMACEUTICALS, INC. ADIL
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2018-07-27
ADIAL PHARMACEUTICALS, INC. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Davidson Matt | Chief Development Officer | 2026-06-12 | Grant | 232,417 | — |
| Davidson Matt | Chief Development Officer | 2026-06-11 | Grant | 3,427 | — |
| Davidson Matt | Chief Development Officer | 2026-06-11 | Grant | 1,822 | — |
| Davidson Matt | Chief Development Officer | 2026-06-11 | Grant | 101 | — |
| Davidson Matt | Chief Development Officer | 2026-06-11 | Grant | 61,647 | — |
| Claiborne Cary J | Chief Executive Officer | 2026-04-07 | Grant | 37,985 | — |
| Goodman Tony | Chief Operating Officer | 2026-04-07 | Grant | 26,510 | — |
| Schuyler Kevin | director | 2026-04-07 | Grant | 9,185 | — |
Source: SEC EDGAR filings · CIK 0001513525 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.